Lyell Immunopharma, Inc. (LYEL)

CIK 1806952 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lyell Immunopharma, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 202640001959742-26-000003
Sep 10, 202630002150331-26-000001
Sep 10, 20268-K0001193125-26-387890
Sep 10, 202640002150331-26-000002
Aug 25, 202640001327111-26-000006
Aug 25, 202640001866154-26-000006
Aug 25, 202640001907345-26-000006
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097073
Aug 11, 202640001866154-26-000004
Aug 11, 202640001327111-26-000004
Aug 11, 202640002095702-26-000005
Aug 11, 202640001907345-26-000004
Aug 6, 202610-Q0001628280-26-054367
Aug 6, 20268-K0001628280-26-054330
Jul 27, 202640001140361-26-029817
Jul 27, 202640001140361-26-029791
Jul 21, 2026EFFECT9999999995-26-002375
Jul 20, 202640001140361-26-028955
Jul 17, 202640001140361-26-028846
Jul 13, 2026S-30001193125-26-302132
Jul 1, 202640001140361-26-027140
Jun 18, 2026SCHEDULE 13G/A0001140361-26-025769
Jun 18, 202630001140361-26-025740
Jun 18, 202640001140361-26-025796
Jun 15, 202640001327111-26-000003